MSP Recovery Debt to Equity Ratio 2020-2025 | MSPR
Current and historical debt to equity ratio values for MSP Recovery (MSPR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. MSP Recovery debt/equity for the three months ending March 31, 2025 was 0.85.
| MSP Recovery Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $2.16B | $-0.36B | -5.96 |
| 2024-12-31 | $2.05B | $-0.13B | -15.95 |
| 2024-09-30 | $1.94B | $0.85B | 2.29 |
| 2024-06-30 | $1.88B | $1.03B | 1.81 |
| 2024-03-31 | $1.79B | $1.24B | 1.44 |
| 2023-12-31 | $1.74B | $1.42B | 1.23 |
| 2023-09-30 | $1.64B | $1.64B | 1.00 |
| 2023-06-30 | $1.61B | $1.80B | 0.89 |
| 2023-03-31 | $1.54B | $2.01B | 0.76 |
| 2022-12-31 | $1.23B | $2.19B | 0.56 |
| 2022-09-30 | $1.18B | $5.39B | 0.22 |
| 2022-06-30 | $1.15B | $5.42B | 0.21 |
| 2022-03-31 | $0.14B | $-0.02B | -7.03 |
| 2021-12-31 | $0.26B | $-0.15B | -1.69 |
| 2021-09-30 | $0.25B | $-0.02B | -12.11 |
| 2021-06-30 | $0.23B | $0.01B | 45.13 |
| 2021-03-31 | $0.23B | $0.01B | 45.19 |
| 2020-12-31 | $0.25B | $-0.02B | -11.79 |
| 2020-09-30 | $0.23B | $0.01B | 45.29 |
| 2020-06-30 | $0.00B | $0.00B | 5.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.018B |
| MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.804B | 58.27 |
| Tempus AI (TEM) | United States | $11.365B | 0.00 |
| Doximity (DOCS) | United States | $10.890B | 50.42 |
| Hims & Hers Health (HIMS) | United States | $9.396B | 97.63 |
| IRhythm Technologies (IRTC) | United States | $4.819B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.834B | 59.90 |
| Hinge Health (HNGE) | United States | $3.409B | 0.00 |
| Privia Health (PRVA) | United States | $2.635B | 180.08 |
| Enovis (ENOV) | United States | $1.711B | 9.54 |
| Phreesia (PHR) | United States | $1.608B | 0.00 |
| Schrodinger (SDGR) | United States | $1.493B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.440B | 0.00 |
| Azenta (AZTA) | United States | $1.334B | 61.98 |
| Omnicell (OMCL) | United States | $1.329B | 23.45 |
| 10x Genomics (TXG) | United States | $1.329B | 0.00 |
| Evolent Health (EVH) | United States | $1.233B | 105.00 |
| Claritev (CTEV) | United States | $0.682B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.588B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.507B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.462B | 138.00 |
| TruBridge (TBRG) | United States | $0.337B | 748.33 |
| Outset Medical (OM) | United States | $0.308B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 4.02 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.103B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |